AI Is Entering the Search Box: Early Lessons for Healthcare Marketing

Generative AI tools are appearing in consumer search in ways that could shift how patients discover allergy and immunology care, the right response right now is measured attention, not reactive change.

A New Variable in Patient Search

Something is changing at the top of the search results page. Microsoft integrated OpenAI's technology into Bing earlier this year, and Google has been testing its own AI-assisted search features in limited rollouts. For most searches, the experience looks roughly the same as it always has. But for a growing subset of queries, including many health-related questions, a conversational, synthesized answer is appearing above or alongside traditional blue links.

This is not a mature technology yet. The rollouts are partial, the outputs are inconsistent, and the major platforms have been public about the limitations. Hallucinated medical facts, outdated citations, and responses that fail basic accuracy tests have all been documented. No practice manager should be rearchitecting their entire digital presence in response to something this early-stage.

That said, the direction of travel is real. Patients searching "what causes seasonal allergies" or "how does allergy immunotherapy work" are beginning to encounter a different kind of result. The question for allergy practices is not whether to act immediately, but how to think clearly about the signal.

What Generative AI Actually Does in Search

Traditional search returns a ranked list of pages. The user clicks through, reads, and forms their own synthesis. Generative AI search tries to collapse that process, it reads multiple sources and produces a single answer. The underlying pages may still appear as citations, but many users will read the synthesized answer and stop there.

For healthcare queries, this has obvious implications. A patient asking "what is the difference between an allergist and an immunologist" may receive a generated paragraph rather than a link to the practice's FAQ page. Whether that paragraph is accurate, and whether it mentions anything that guides the patient toward booking an appointment, is partly outside any individual practice's control.

Understanding this distinction, AI as answer-generator versus AI as traffic-referrer, matters for setting expectations. The model is still evolving, and the platforms themselves have not settled on how citations and source attribution will ultimately work.

Why Allergy and Immunology Is Particularly Exposed

Allergy and immunology patients tend to be research-oriented. A parent investigating a child's suspected food allergy, an adult newly diagnosed with asthma, or a patient considering biologic therapy for their condition, these individuals often conduct substantial searches before they ever call a practice. They are exactly the kind of information-seeking patient that generative AI search targets.

The specialty is also heavily question-driven. "When is allergy season in my area?" "Does sublingual immunotherapy work as well as shots?" "What biologics are approved for severe asthma?" These are the types of informational queries where AI-generated answers are most likely to appear. If practices have not built clear, authoritative content around these questions, they have less presence in the source pool that AI systems draw from.

This is not an immediate crisis. It is an early flag. Practices that have historically relied on SEO traffic to informational pages, pages that explain immunotherapy protocols, allergy testing processes, or what to expect at an initial appointment, should track whether that traffic is changing over the coming months.

What the Evidence Actually Says (and Doesn't)

At this point in mid-2023, there is more speculation than data about how AI search features are affecting healthcare website traffic. Bing's market share remains small relative to Google. Google's AI search features are not yet widely rolled out. The effect on any individual practice's organic traffic is, at this stage, likely negligible.

That is not license to ignore the subject. It is a reminder to demand specificity. When vendors begin selling AI search optimization as a new service category, practices should ask what concrete evidence exists for the intervention, what would success look like, and how it would be measured. Healthy skepticism is appropriate for any marketing trend in its earliest stage.

The honest assessment right now: monitor, understand the mechanism, do not overinvest, do not dismiss.

The Foundation That Matters Regardless

Whatever generative AI search eventually becomes, one factor works in the same direction it always has, the quality of the practice's own content. AI systems synthesize information from existing sources. Practices that have published clear, accurate, well-organized content about allergy testing, immunotherapy, biologics, and asthma management are in a better position as source material than practices with thin or outdated pages.

This is not a novel recommendation. It is the same principle that has governed healthcare SEO for years: write for patients, write accurately, write with depth. The practical value of strong educational content has not changed. If anything, the emergence of AI as a potential intermediary makes the quality of the underlying source material more relevant, not less.

Practices should treat any AI-driven content conversation as an opportunity to audit what they have published, not as a prompt to produce content at scale through AI tools that may introduce their own accuracy risks.

Local Search Signals Remain Stable

While informational search is the area most likely to be disrupted by AI features, local search, the map pack, the "allergist near me" results, the Google Business Profile, shows no meaningful change. AI-generated answers are appearing primarily for informational queries, not for local commercial queries where a patient is actively trying to find and book a provider.

This means the fundamentals of local SEO remain exactly as important as they were. Maintained and verified Google Business Profiles, accurate hours and contact information, review volume and recency, and consistent NAP (name, address, phone) data across directories continue to drive visibility for patients who are ready to schedule. These signals are not affected by what happens at the top of a national informational search result.

For practices allocating marketing resources, local search deserves continued, disciplined attention. It is the channel most directly connected to appointment generation, and it is the channel least affected by the current AI disruption conversation.

PCP Referrals Are a Useful Counterweight

Allergy practices that have invested in primary care referral relationships have a degree of insulation from any search-driven volatility. When a pediatrician proactively refers a patient for allergy testing, or when an internist recommends an allergist for a patient with difficult-to-control asthma, that appointment does not pass through a search engine. The referral relationship is the channel.

This is not an argument for abandoning digital. Most new patients still pass through some digital touchpoint, whether that is searching for the practice after receiving a referral name or researching the practice's credentials before their first appointment. But referral networks represent a meaningful share of allergy practice volume, and they are entirely disconnected from whatever is happening with generative AI search.

Practices that have not formally cultivated PCP relationships, through lunch-and-learns, continuing education events, direct outreach to primary care offices, or streamlined referral processes, have a development opportunity that pays returns regardless of what happens in digital.

Advertising Is Not Disrupted, Yet

Paid search advertising, including Google Ads campaigns that target allergy-related keywords, operates on a different system than organic search results. AI-generated answers and paid ads are currently separate tracks. A practice running paid search ads for terms like "allergy testing" or "immunotherapy for hay fever" is not competing with AI-generated summaries in the same way that organic pages are.

This remains one of the more stable channels available to allergy practices for driving new patient acquisition, particularly during peak seasonal demand, spring tree pollen season, summer grass season, fall ragweed season. Paid search can be turned on, calibrated to specific geographic radii, and measured with precision that organic search cannot match.

The practical implication: practices should not deprioritize paid search budgets in response to AI search noise. The AI disruption discussion, to the extent it has practical implications, is an organic and content-side question, not a paid media question.

How to Follow This Story Without Getting Distracted

Generative AI in search is a story worth following. It is not a story worth consuming all available attention. The pace of change has been slower than the press coverage suggests, and the marketing services industry has a financial incentive to position the development as an emergency requiring immediate intervention.

A reasonable monitoring posture: check organic traffic to key informational pages quarterly, pay attention to industry reporting from credible healthcare marketing and SEO sources, and revisit assumptions if traffic trends begin showing unexplained changes. Set a calendar reminder to reassess six months from now, and again at the one-year mark. The technology and its market penetration will be clearer then.

Within the practice, the most productive internal conversation is not "how do we optimize for AI search", no one knows what that means yet, but "how strong is the content we have published, and does it accurately represent what patients need to know about our services?"

Looking Ahead

Generative AI search will mature. The current moment is one of genuine uncertainty, and that uncertainty is uncomfortable but also clarifying. Practices that chase every new development will exhaust resources on interventions that may prove irrelevant. Practices that tune the signal out entirely may find themselves behind a trend that does eventually change patient behavior in measurable ways.

The steady path is to maintain strong content fundamentals, protect local search presence, sustain referral relationships, and watch without overreacting. Allergy and immunology is a specialty built on careful diagnostic reasoning, the same disciplined approach applies here. Evaluate the evidence as it develops, draw conclusions when the data supports them, and resist the pressure to act urgently on signals that are still too early to read clearly.